Table 1. Study population characteristics and baseline measures.
Characteristics and fasting laboratory measures of the study group.
Variation is described by either mean ± standard deviation or median with (interquartile range, IQR)
Normal ranges or recommended (rec) levels are provided where available (uln: upper limit of normal)
| Fasting Measures | Normal Range | |
|---|---|---|
| Age (years) | 15 ± 5 | |
| GFR (ml/min/1.73m2) | 53 ± 30 | > 70 by equation |
| urine protein/creatinine (mg/mg) |
0.8 ± 1.0 | < 0.2 |
| Serum Albumin (g/dl) | 4.5 ± 0.5 | 3 – 5 |
| BMI (kg/m2) | 22 (18–29) | (age/sex dependent) |
| BMI Z score | 1.07 ± 1.28 | 0 ± 2 |
| Waist Circumference Z score | −0.05 ± 0.71 | 0 ± 2 |
| Insulin (μIU/ml) | 12.79 ± 6.5 | 5 – 15 (age dependent) |
| HOMA-IR | 2.40 (1.7–3.8) | < 2.5 (puberty dependent) |
| Total TG (mg/dl) - median (IQR) |
121 (90–175) | < 130 (age dependent) |
| Total Cholesterol (mg/dl) | 176 ± 53 | < 200 |
| HDL-C (mg/dl) | 42 ± 7 | > 40 (guideline) |
| Non-HDL-C (mg/dl) | 132 ± 51 | < 130 (guideline) |
| LDL-C (mg/dl) | 81 ± 30 | < 100 (guideline) |
| VLDL-TG (mg/dl) - median (IQR) |
58 (42–98) | - |
| ApoA1 (mg/dl) | 133 ± 21 | 104–225 |
| ApoB (mg/dl) | 84 ± 27 | 60–133 |
| ApoB-48 (ng/L) | 11.3 ± 5.3 | 1.4 – 9 |
| ApoC-III (mg/dl) | 12.4 ± 4.7 | < ~9 (age dependent) |
| Lp(a) (mg/dl) - median (IQR) | 17 (6–59) | uln 14.6 M / 17.6 F |
| TNF-alpha (pg/mL) | 2.5 ± 1.3 | 0.55–2.82 |
| IL-6 (pg/mL) | 1.5 ± 1.1 | 0.45–9.96 |
| Free Fatty Acids (mMol/L) | 0.6 ± 0.5 | 0.1–0.6 |